Laurie Baker, the EVP - Chief Operating Officer of $CPT, sold 384 shares of the company on 01-05-2026 for an estimated $42,171. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4% of their shares of this class of stock. Following this trade, they now own 96,786 shares of this class of $CPT stock.
$CPT Insider Trading Activity
$CPT insiders have traded $CPT stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CPT stock by insiders over the last 6 months:
- RICHARD J CAMPO (Chairman and CEO) has made 0 purchases and 3 sales selling 43,621 shares for an estimated $4,790,957.
- ALEXANDER J. JESSETT (President & CFO) sold 5,627 shares for an estimated $617,236
- KELVIN R WESTBROOK sold 2,225 shares for an estimated $244,064
- HEATHER J. BRUNNER sold 2,104 shares for an estimated $230,791
- LAURIE BAKER (EVP - Chief Operating Officer) has made 0 purchases and 3 sales selling 681 shares for an estimated $74,826.
- STEVEN A WEBSTER sold 154 shares for an estimated $16,814
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CPT Hedge Fund Activity
We have seen 261 institutional investors add shares of $CPT stock to their portfolio, and 300 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIKING GLOBAL INVESTORS LP added 1,130,718 shares (+41.6%) to their portfolio in Q3 2025, for an estimated $120,738,068
- VICTORY CAPITAL MANAGEMENT INC removed 1,015,579 shares (-23.4%) from their portfolio in Q3 2025, for an estimated $108,443,525
- LONG POND CAPITAL, LP added 922,956 shares (+90.2%) to their portfolio in Q3 2025, for an estimated $98,553,241
- FMR LLC added 810,607 shares (+17.5%) to their portfolio in Q3 2025, for an estimated $86,556,615
- JENNISON ASSOCIATES LLC removed 409,251 shares (-40.4%) from their portfolio in Q3 2025, for an estimated $43,699,821
- BLACKROCK, INC. added 354,530 shares (+3.2%) to their portfolio in Q3 2025, for an estimated $37,856,713
- CI INVESTMENTS INC. removed 339,284 shares (-85.7%) from their portfolio in Q3 2025, for an estimated $36,228,745
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CPT Revenue
$CPT had revenues of $398.2M in Q3 2025. This is an increase of 2.39% from the same period in the prior year.
You can track CPT financials on Quiver Quantitative's CPT stock page.
$CPT Analyst Ratings
Wall Street analysts have issued reports on $CPT in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/15/2025
- Mizuho issued a "Outperform" rating on 11/24/2025
- Goldman Sachs issued a "Sell" rating on 09/17/2025
- Stifel issued a "Buy" rating on 08/26/2025
- Citigroup issued a "Buy" rating on 08/14/2025
To track analyst ratings and price targets for $CPT, check out Quiver Quantitative's $CPT forecast page.
$CPT Price Targets
Multiple analysts have issued price targets for $CPT recently. We have seen 16 analysts offer price targets for $CPT in the last 6 months, with a median target of $115.0.
Here are some recent targets:
- Anthony Paolone from JP Morgan set a target price of $116.0 on 12/18/2025
- Michael Lewis from Truist Securities set a target price of $116.0 on 12/15/2025
- Richard Hightower from Barclays set a target price of $118.0 on 11/25/2025
- James Feldman from Wells Fargo set a target price of $110.0 on 11/25/2025
- Haendel St. Juste from Mizuho set a target price of $114.0 on 11/24/2025
- Adam Kramer from Morgan Stanley set a target price of $123.0 on 11/13/2025
- Joshua Dennerlein from B of A Securities set a target price of $137.0 on 11/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
